Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Piper vs VyrarX

By GLP-1 ScorecardUpdated

PiperFactor scores not reassessed.
Site position #29

Higher score

VyrarXFactor scores not reassessed.
Site position #160

Lower score

Score comparison

Piper has the higher recorded score — 81.9/100 to 68.6/100.

Piper grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Now branded Polly; compare its complete payment schedule.

Before you choose

Before comparing the headline prices, the Piper review and the VyrarX review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.

If neither one fits, Piper vs Zeuss and Rx.com vs VyrarX compare each of them with another graded program, and the list of alternatives to Piper ranks the programs closest to Piper on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

Of the sellers that pay us a commission, the HealthRX review covers one graded close to these two, at 77.5/100. That relationship never changes a grade, and the review lists what we could not verify.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valuePiper +25
86
61
Dose & formulationPiper +16
80
64
Clinical oversightVyrarX +5
79
84
Labs & monitoringPiper +6
78
72
FulfillmentPiper +15
86
71
Contract termsPiper +27
82
55
Piper · top barVyrarX · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricPiperVyrarX
WeighScore81.9/10068.6/100
GradeB−C
Site position#29#160
Semaglutide$179 monthly; $135/month equivalent with six months prepaid.From $179/mo (advertised injectable program)
Tirzepatide$279/mo month-to-month; $199/mo equivalent requires six months and $1,194 prepaid.From $329/mo (advertised program)
CoverageAll-state access claimed; confirm individual eligibility.Coverage not published
Brand-name accessNot confirmedNot confirmed
Oral / sublingualNot confirmedNot confirmed
Piper

Site position #29 · B−

Factor scores not reassessed.

Strengths

  • Price FAQs distinguish monthly and prepaid plans.
  • All-state access is advertised; individual eligibility needs confirmation.
  • Advertises compounded injectable semaglutide and tirzepatide.

What to consider

  • Assigned clinicians and dispensing facilities need confirmation.
  • Refund cutoffs differ across public pages.
  • Confirm the selected monitoring, billing and supply schedule.
VyrarX

Site position #160 · C

Factor scores not reassessed.

Strengths

  • Publishes starting prices for both weight-loss programs
  • Advertises one-to-one provider messaging and free shipping
  • Names Rush Pharmacy in its public FAQ

What to consider

  • Starting prices do not establish the selected dose or renewal charge
  • Partial billing periods are generally not refunded
  • The homepage advertises 47 states without listing them

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard